One of the faster growing pharmaceutical litigations involves the diabetes drug, Invokana. Recent news indicates that settlements are being reached among various plaintiffs over the…

In 2012, credit card companies reached the largest antitrust settlement in history with merchants over interchange fees – a $7.25 billion deal that was ultimately rejected by…